ARTICLE | Clinical News
Metabasis regulatory update
March 2, 1998 8:00 AM UTC
Metabasis received notice of allowance for a U.S. patent covering a series of adenosine kinase inhibitors and their use to treat inflammation, pain and neurological diseases. Metabasis is a majority-...